Henan Cancer Hospital — Henan

Public research footprint of Henan Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma · Platinum-resistant Ovarian Cancer · Multiple Myeloma in Relapse

Recently updated registry entries

NCT04656652 — Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small… (Active Not Recruiting)
NCT04603040 — A Study to Evaluate the Efficacy and Safety of Toripalimab Injection in the Treatment of… (Terminated)
NCT06095583 — Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Henan Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.